Adjusted per-share earnings in the fourth quarter for UnitedHealth top analysts’ estimates but revenue comes up short.

But high medical costs contributed to results that disappointed Wall Street, and the company’s stock fell on the news that it had made less than analysts expected.

UnitedHealth Group’s upcoming earnings call marks the company's first public appearance since the murder of UnitedHealthcare CEO Brian Thompson.

UnitedHealth Group (NYSE:UNH) reported the fourth-quarter 2024 earnings and reaffirmed 2025 guidance. The company reported adjusted EPS of $6.81, up from $6.16 a year ago, beating the consensus of $6.

Revenue grew to over $400 billion, but still missed growth targets.

The CEO of UnitedHealth Group has defended its role in America's health system as the company posted its first earnings results since the murder of one of its top executives. Sir Andrew Witty spoke to analysts as the firm reported mixed results,

The UnitedHealth Group leader whose murder in December unleashed a torrent of public frustration and dissatisfaction with the U.S. health care system was pushing for some of the very improvements that critics have been seeking.

Bernstein analysts maintained their positive stance on UnitedHealth Group (NYSE:UNH) shares, reiterating an Outperform rating and a price target of $697.00. The reaffirmation follows UnitedHealth's latest quarterly financial report,

UnitedHealth shares dropped nearly 5% Thursday morning after the firm disclosed worse-than-expected revenue in its first earnings report since the shocking assassination of Brian Thompson, its insurance branch’s chief executive.